Wealth Advisors of Tampa Bay’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,810
Closed -$660K 93
2025
Q3
$660K Sell
9,810
-16,415
-63% -$1.3M 0.22% 69
2025
Q2
$2.29M Buy
26,225
+5,670
+28% +$444K 0.86% 45
2025
Q1
$1.4M Buy
20,555
+3,265
+19% +$266K 0.57% 53
2024
Q4
$1.34M Buy
17,290
+2,238
+15% +$166K 0.58% 55
2024
Q3
$1.01M Buy
15,052
+340
+2% +$27.9K 0.42% 63
2024
Q2
$1.67M Hold
14,712
0.78% 45
2024
Q1
$2.04M Buy
14,712
+397
+3% +$49.9K 0.97% 41
2023
Q4
$1.78M Sell
14,315
-12,045
-46% -$1.23M 0.89% 46
2023
Q3
$2.46M Buy
26,360
+19,185
+267% +$2.16M 0.68% 50
2023
Q2
$922K Buy
+7,175
New +$868K 0.51% 57

Other funds holding DXCM

Wealth Advisors of Tampa Bay's DXCM Position: Q4 2025 in Review

Wealth Advisors of Tampa Bay sold out of DexCom (DXCM) in Q4 2025, closing a stake of 9,810 shares — an estimated $660K sold.

Wealth Advisors of Tampa Bay first reported a position in DXCM in Q2 2023 and held it in 10 quarters. The position peaked at $2.46M in Q3 2023. 921 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Wealth Advisors of Tampa Bay reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Wealth Advisors of Tampa Bay sold 9,810 DexCom shares in Q4 2025, an estimated $660K.
  • Wealth Advisors of Tampa Bay first reported a position in DexCom in Q2 2023 and held it in 10 quarters.
  • Wealth Advisors of Tampa Bay's DexCom position peaked at $2.46M in Q3 2023.
  • 921 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Wealth Advisors of Tampa Bay's 13F filing for Q4 2025, filed 9 Feb 2026.